The effect of cytostatics and hyperthermia on RAJI human lymphoma cells

Experimental Oncology

Volumn 33, Issue 1, 2011, Pages 19-23

  Istomin, Yu D ^a   Zhavrid, E A ^a   Sachivko, N V ^a   Alexandrova, E N ^a   Pocheshinsky, P V ^a  

^a NN Alexandrov National Cancer Center of Belarus   (Belarus)

Author keywords

Hyperthermia; RAJI human lymphoma cells; Thermochemotherapy

Indexed keywords

CARBOPLATIN; CARMUSTINE; CHEMOCARB; CISPLATIN; CITOGEM; ETOPOSIDE; GEMCITABINE; OXALIPLATIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CULTURE; CELL GROWTH; CELL LEVEL; CONTROLLED STUDY; CYTOSTASIS; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENTIATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IC 50; LYMPHOMA; LYMPHOMA CELL LINE; RAJI CELL; TEMPERATURE; THERMAL STIMULATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOSTATIC AGENTS; HOT TEMPERATURE; HUMANS;

EID: 79953089264     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Zhavrid EA, Osinsky SP, Fradkin SZ. Hyperthermia and hyperglycemia in oncology. Kiev: Naukova dumka, 1987. 256 p. (In Russian).
2. Westermann AM, Wiedemann GJ, Jager E, et al. A systemic hyperthermia Oncologic Working Group trial: ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma. Oncology 2003, 64: 312-21. (Pubitemid 36682942)
3. Douwes F, Bogovič J, Douwes O, et al. Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer. Int J Clin Oncol 2004; 9: 85-91. (Pubitemid 38647165)
4. Shem BC, Lundh T, Froystein T, et al. Whole body hyperthermia combined with ifosfamide and carboplatin in recurrent ovarian carcinoma. A phase I-II study. In: Book of Abstracts of 23rd Ann Meeting of the Eur Soc for Hyperthermic Oncology, Charite, Berlin, May 24-27. Berlin, 2006: 60.
5. Bruns I, Kohlmann T, Wiedemann GJ, et al. Evaluation of the therapeutic benefit of 41.8 degrees C whole-body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS). Pneumologie 2004; 58: 210-16.
6. Ismail-zade RS. Controlled whole-body hyperthermia in the management of far-advanced malignant tumors in children. Minsk: Econompress, 2007. 167 p. (In Russian).
7. Rowe-Horwege RW. Hyperthermia, systemic. Encyclopedia of medical devices and instrumentation, 2nd ed. New York: John Woley & Sons, Inc, 2006: 42-62 pp.
8. Hildebrandt B, Hegewisch-Becker S, Kerner T, et al. Current status of radiant whole-body hyperthermia > 41.5 degrees C and practical guidelines for the treatment of adults. The German Interdisciplinary Working Group on Hyperthermia. Int J Hyperthermia 2005; 21: 169-83. (Pubitemid 40360758)
9. Karev ID, Rodina AA, Gut NV, et al. Whole-body high-frequency hyperthermia in the management of disseminated chemoresistant tumors. In: Book of abstracts, III Congress of CIS oncologists and radiologists, May 25-28, 2004. Minsk, 2004, part 1: pp. 146-9 (In Russian).
10. Bull JMC, Scott GL, Strebel FR, et al. Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-α: A description of a phase I-II protocol. Int J Hyperthermia 2008; 24: 649-62.
11. Hahn GM. Potential for therapy of drugs and hyperthermia. Cancer Res 1979; 39: 2264-8. (Pubitemid 9185421)
12. Mauz-Körholz C, Dietzsch S, Banning U, et al. Mechanisms of hyperthermia- and 4-hydroperoxy-ifosfamide-induced cytotoxicity in T cell leukemia. Anticancer Res 2002; 22: 4243-47. (Pubitemid 36134466)
13. Schem BC, Mella O, Dahl O. Thermochemotherapy with cisplatin or carboplatin in the BT4 rat glioma in vitro and in vivo. Int J Radiat Oncol Biol Phys 1992, 23:109-14.
14. Urano M, Ling CC. Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro. Int J Hyperthermia 2002, 18: 307-15. (Pubitemid 34700198)
15. Debes A, Willers R, Gobel U, et al. Role of heat treatment in childhood cancers: distinct resistance profiles of solid tumor cell lines towards combined thermochemotherapy. Pediatr Blood Cancer 2005, 45: 663-9. (Pubitemid 41279357)
16. Haveman J, Rietbroek RC, Geerdink A, et al. Effect of hyperthermia on the cytotoxicity of 2′,2′-difluorodeoxy-cytidine (gemcitabine) in cultured SW1573 cells. Int J Cancer 1995, 62: 627-30.
17. Urano M, Majima H, Miller R, et al. Cytotoxic effect of 1,3 bis (2-chloroethyl)-N-nitrosourea at elevated temperatures: Arrhenius plot analysis and tumor response. Int J Hyperthermia 1991, 7: 499-510.
18. Urano M, Begley J, Reynolds R. Interaction between adriamycin cytotoxicity and hyperthermia: growth-phase-dependent thermal sensitization. Int J Hyperthermia 1994, 10: 817-26. (Pubitemid 24352989)
19. Hermisson M, Weller M. Hyperthermia enhanced chemosensitivity of human malignant glioma cells. Anticancer Res 2000, 20: 1819-23. (Pubitemid 30628207)
20. Choi EK, Park SR, Lee JH, et al. Induction of apoptosis by carboplatin and hyperthermia alone or combined in WERI human retinoblastoma cells. Int J Hyperthermia 2003; 19: 431-43. (Pubitemid 36798301)
21. Souslova T, Averill-Bates DA. Multidrug-resistant HeLa cells overexpressing MRP1 exhibit sensitivity to cell killing by hyperthermia: interactions with etoposide. Int J Radiat Oncol Biol Phys 2004; 60: 1538-51. (Pubitemid 39601872)
22. Van Bree C, Beumer C, Rodermond HM, et al. Effectiveness of 2′,2′difluorodeoxycytidine (gemcitabine) combined with hyperthermia in rat R-1 rhabdomyosarcoma in vitro and in vivo. Int J Hyperthermia 1999; 15: 549-56. (Pubitemid 29516382)
23. Van der Heijden AG, Verhaegh G, Jansen CF, et al. Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study. J Urol 2005; 173: 1375-80. (Pubitemid 40380578)
24. Wei HM, Guo KY, Mei JZ, et al. Thermotherapy enhances the sensitivity of lymphoma cell line RAJI to chemotherapy in vitro. Nan Fang Yi Ke Da Xue Xue Bao 2007; 27: 709-11 (In Chinese).
25. Michalakis J, Georgatos SD, de Bree E, et al. Short-term exposure of cancer cells to micromolar doses of paclitaxel, with or without hyperthermia, induces long-term inhibition of cell proliferation and cell death in vitro. Ann Surg Oncol 2007; 14: 1220-8.
26. Hildebrandt B, Wust P. Interaction between hyperthermia and cytotoxic drugs. Cancer Treat Res 2007; 134: 185-93.
27. Issels RD. Hyperthermia adds to chemotherapy. Eur J Cancer 2008; 44: 2546-54.
28. Mohamed F, Marchettini P, Stuart OA, et al. Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia. Ann Surg Oncology 2003; 10: 463-8. (Pubitemid 40486946)
29. Vertrees RA, Das GC, Popov VL, et al. Synergistic interaction of hyperthermia and gemcitabine in lung cancer. Cancer Biol Ther 2005; 10:1144-53. (Pubitemid 41598572)